Global Dermatology Coalition Launched to Improve Health Outcomes for People Living with Dermatological Diseases Worldwide
25 May 2022
Today, at the 75th World Health Assembly in Geneva, the ILDS is pleased to share the announcement of the launch of the Global Dermatology Coalition. This Coalition brings together a multi-stakeholder group of like-minded organisations focused putting medical dermatology on the global health agenda.
The ILDS is committed to representing dermatology professionals, including our 190+ member organisations from more than 90 countries, and working with patient organisations to improve skin health for patients all around the world. As a founding partner of the Global Dermatology Coalition, we look forward to utilising resources to foster collaboration, strengthen partnerships, develop networks to facilitate opportunities to raise awareness of the cross-cutting nature of skin health and impact global health policy. The ILDS is committed to the inclusion of the patient voice in our work; this coalition is part of a meaningful engagement in achieving that goal, and to improve the health and quality of life for patients.
The Global Dermatology Coalition will advocate to the World Health Organization (WHO) and other decision makers globally to elevate the healthcare prioritisation of dermatological diseases. The multi-stakeholder group is focused on improving patient outcomes globally by raising awareness of the burdensome and multi-faceted impacts of these conditions.
For more information visit https://globalskin.org/GlobalDermatologyCoalition
The Global Dermatology Coalition is comprised of the following 20 organisations:
- Bristol-Myers Squibb
- Cutaneous Lymphoma Foundation
- Dermatology Nurses Association
- European Federation of Allergy and Airways Diseases Patients’ Associations (EFA)
- European Society for Dermatological Research (ESDR)
- International Alliance of Dermatology Patient Organizations (GlobalSkin)
- International Alliance of Patient Organizations (IAPO)
- International League of Dermatological Societies (ILDS)
- International Pemphigus Pemphigoid Foundation (IPPF)
- La Roche-Posay International
- LEO Pharma
- Lupus Europe
- Naevus Global
- Pediatric Dermatology Research Alliance (PeDRA)